Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 464.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000099 (2000)	J. Fine [Canada] ; J. Duff ; R. Chen ; B. Chir ; W. Hutchison ; A M Lozano ; A E Lang	Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease.
000107 (????)	D J Chong [Canada] ; O. Suchowersky ; C. Szumlanski ; R M Weinshilboum ; R. Brant ; N R Campbell	The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.
000110 (2000)	M. Cyr [Canada] ; F. Calon ; M. Morissette ; M. Grandbois ; T. Di Paolo ; S. Callier	Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS.
000117 (2000)	M. Goulet [Canada] ; R. Grondin ; M. Morissette ; S. Maltais ; P. Falardeau ; P J Bédard ; T. Di Paolo	Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys.
000125 (2000)		Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
000128 (2000)	J S Frank [Canada] ; F B Horak ; J. Nutt	Centrally initiated postural adjustments in parkinsonian patients on and off levodopa.
000131 (2000)	A. Klegeris [Canada] ; P L Mcgeer	R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
000134 (2000)	E. Mohr [Canada] ; T. Mendis ; K. Hildebrand ; P P De Deyn	Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial.
000139 (2000)	P. Watkins [États-Unis]	COMT inhibitors and liver toxicity.
000150 (2001)	R. De La Fuente-Fernández [Canada] ; J Q Lu ; V. Sossi ; S. Jivan ; M. Schulzer ; J E Holden ; C S Lee ; T J Ruth ; D B Calne ; A J Stoessl	Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
000153 (2001)	S B Patten [Canada] ; J V Williams ; R. Petcu ; R. Oldfield	Delirium in psychiatric inpatients: a case-control study.
000156 (2001)	H. Moller	Antiparkinsonian drugs and "sleep attacks".
000162 (2001)	J E Ahlskog [États-Unis] ; M D Muenter	Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.
000164 (2001)	M. Guttman [Canada] ; D. Stewart ; D. Hussey ; A. Wilson ; S. Houle ; S. Kish	Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.
000166 (2001)	R. Levy [Canada] ; J O Dostrovsky ; A E Lang ; E. Sime ; W D Hutchison ; A M Lozano	Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease.
000170 (????)	O. Suchowersky [Canada] ; P. Bailey ; E. Pourcher ; L. Bulger ; G. Facciponte	Comparison of two dosages of tolcapone added to levodopa in nonfluctuating patients with PD.
000171 (????)	D S Sa [Canada] ; S. Kapur ; A E Lang	Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis.
000175 (2001)	R. De La Fuente-Fernández [Canada] ; T J Ruth ; V. Sossi ; M. Schulzer ; D B Calne ; A J Stoessl	Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
000183 (2001)	A H Rajput [Canada]	The protective role of levodopa in the human substantia nigra.
000188 (2001)	R. Levy [Canada] ; A E Lang ; J O Dostrovsky ; P. Pahapill ; J. Romas ; J. Saint-Cyr ; W D Hutchison ; A M Lozano	Lidocaine and muscimol microinjections in subthalamic nucleus reverse Parkinsonian symptoms.
000190 (2001)	R. De La Fuente-Fernández [Canada] ; A S Lim ; V. Sossi ; J E Holden ; D B Calne ; T J Ruth ; A J Stoessl	Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022